正版 药理学 娄建石主编 清华大学出版社 9787302384830 书籍

Chapter 1  Introduction
  I. Development of Pharmacology
  II. New Drug Research
Chapter 2  Pharmacodynamics
  I. General Classification of Drug Effects
  II. Dose-Effect Relationship
  III. Receptor Theory and Drug Receptor Interaction
  IV. Receptor Families and Their Transducer and Effector Molecules
  V. Relationship Between Regulatory Mechanisms of Receptors and the Pharmacological Action
  VI. Mechanism of Action
Chapter 3  Pharmacokinetics
  I. Drug Transport across Membranes
  II. The Dynamics of Drug Absorption, Distribution, and Elimination
  II. General Principles of Pharmacokinetics
Chapter 4  Pharmacogenetics
  I. The Objectives of Research in Pharmacogenetics
  II. The Effect of Genetic Factors on Drug Reactions
  III. The Racial Difference of Drug Reaction and Metabolism
Chapter 5  Autonomic Pharmacology
  I. Anatomy and Neurotransmitter Chemistry of the Autonomic Nervous System
  II. Biosynthesis and Metabolism of Transmitters
  III. Locations of Autonomic Receptors
  IV. Presynaptic Regulation of Transmitter Release
  V. Functional Organization of Autonomic Activity
  VI. Coupling Mechanism of Receptor-effect
  VII. Mode of Action of Autonomic Nervous System Drugs
  VIII. Classification of Autonomic Nervous System Drugs
Chapter 6  Cholinoceptor-Activating and Cholinesterase-lnhibiting Drugs
  I. Direct-acting Cholinoceptor Stimulants
  II. Cholinesterase Inhibitors
Chapter 7  Organophosphates Anticho:inesterase Intoxication and Cholinesterase Reactivators...
  I. Organophosphates Anticholinesterase Intoxication
  II. Cholinesterase Reactivator
Chapter 8  M CholinoceptorAntagonists
  I. Natural M Cholinoceptor Blocking Drugs
  II. Synthetic Spasmolytic Drugs
Chapter 9  N CholinoceptorAntagonists
  I. N1 Cholinoceptor Blocking Drugs
  II. N2 Cholinoceptor Blocking Drugs
Chapter 10  Adrenoceptor-Activating Drugs
  I. Chemical Structure
  II. Classification
  III. Mixed α and β Receptor Agonists
  IV. α Receptor Agonists
  V. β Receptor Agonists
  VI. Dopaminergic Receptor Agonists
Chapter 11  Adrenoceptor Blocking Drugs
  I. a Receptor Antagonists
  II. β Receptor Antagonists
  III. a, β Receptor Antagonists
Chapter 12  Sedative-Hypnotics Drugs
  I. Introduction
  II. Benzodiazepines
  III. Barbiturates
  IV. Other Sedative-Hypnotics
Chapter 13  Antiepileptic Drugs
  I. Classification of Seizure Types
  II. Drugs Used in Seizures
  III. Selectivity and Withdrawal of Antiepileptic Drugs
  IV. Anticonvulsant Drugs
Chapter 14  Psychotropic Drugs
  I. Antipsychotic Drugs
  II. Antimanic Drugs
  III. Antidepressants
Chapter 15  Antiparkinsonism Drugs
  I. Dopaminergic Drugs
  II. Anticholinergic Drugs
  III. Others
Chapter 16  Antipyretic-Analgesic and Antiinflammatory Drugs
  I. Introduction
  II. Salicylates
  III. Anilines
  IV. Pyrazolones
  V. Others
  VI. Analgesic Compounds
  VII. Slow Acting Antirheumatic Drugs
  VIII. Antigout Drugs
Chapter 17  Narcotic Analgesics
  I. Introduction
  II. Opioid Receptor Agonists
  III. Opioid Receptor Antagonists
Chapter 18  Central Stimulants
  I. Cerebral Stimulants
  II. Medullary Stimulants
Chapter 19  Drugs Used in the Treatment of Heart Failure
  I. Pathophysiology of Congestive Heart Failure
  II. Diuretics
  lII. Aldosterone Antagonists
  IV. Inhibitors of RAAS: ACEI and AT1 Receptor Antagonists
  V. β Adrenergic Receptor Blocking Agents
  VI. Vasodilators
  VII. Cardiac Glycosides
  VS. [3 Adrenergic Receptor Stimulators
  IX. Phosphodiesterase Inhibitors
Chapter 20  Antihypertensive Drugs
  |. Introduction
  II. Drugs that Alter Sodium and Water Balance
  Ill. Drugs that Alter Sympathetic Nervous System Function
  IV. Vasodilators
  V. Drugs that Interfere with the Renin-Angiotensin System
  VI. Clinical Pharmacology of Antihypertensive Drugs
Chapter 21  Anti-Angina Pectoris Drugs
  I. Introduction
  II. Nitrates and Nitrites
  III. Calcium Channel Blockers
  IV. /3 Receptor Antagonists
Chapter 22  Antiarrhythmic Drugs
  I. Introduction
  II. Class I A
  III. Class I B
  IV. Class I c
  V. Class II
  VI. Class III
  VII. Class IV
  VIII. Others
Chapter 23  Autihyperlipidemic Drugs
  I. Atherogenesis
  II. Lipoprotein Transport
  III. Dyslipidaemia
  IV. Antihyperlipidemic Drugs
Chapter 24  Diuretic and Dehydrant Drugs
  I. Kidney Structure and Function
  II. Diuretics
  III. Osmotic Diuretics (Mannitol, Sorbitol, Glucose, Urea)
Chapter 25  Antiasthmatie Drugs
  I. Bronchodilators
  II. Anti-Inflammatory Drugs
Chapter 26  Drugs Used in Gastrointestinal Diseases
  I. Drugs Used to Treat Peptic Ulcer
  1I. Antiemetic Drugs
  III. Antidiarrheal Drugs
  IV. Laxatives.
Chapter 27  Drugs Affecting Uterine Motility
  I. Drugs that Stimulate Uterine Contraction
  II. Drugs that Inhibit Uterine Contraction
Chapter 28  Anticoagulants and Coagulants
  I. Introduction
  II. Anticoagulants
  III. Antiplatelet Drugs
  IV. Fibrinolytic Drugs
  V. Coagulants
Chapter 29  Histamine and Antihistamine Drugs
  I. Histamine
  II. H1 Receptor Antagonists
  III. H2 Receptor Antagonists
Chapter 30 Adrenocorticosteroids
  I. Introduction
  II. Glucocorticoids
  III. Mineralocorticoids
Chapter 31  Drugs Affecting the Thyroid Gland
  I . Thyroid Hormone (TH)
  II. Antithyroid Drugs
Chapter 32  Antidiabetic Drugs
  I. Insulin
  II. Oral Hypoglycemic Drugs
  III. Current Treatment Options
Chapter 33  Introduction to Antibacterial Drugs
  I. Specialty Terms
  H. Antimicrobial Mechanisms
  III. Mechanism of Resistance to Antibiotics
Chapter 34  SyntheticAntimicrobial Drugs
  I. Sulfonamides
  II. Trimethoprim
  III. Quinolones
Chapter 35  β-Lactam Antibiotics
  I. Penicillins
  II. Cephalosporins
  III. Other β-Lactam Drugs
Chapter 36  Macrolides, Lincosamides and Glycopeptides
  I. Macrolides
  II. Lincosamides
  III. Glycopeptides
Chapter 37  Broad-Spectrum Antibiotics
  I. Tetracyclines
  II. Chloramphenicols
Chapter 38  Aminoglycosides and Polypeptides
  I. Aminoglycosides
  II. Polypeptides
Chapter 39  Antifungal Drugs
  I. Antibiotics
  II. Azole Antifungal Drugs
  11I. Allylamine Antifungal Drugs
  IV. Pyrimidine Antifungal Drugs
Chapter 40  Antiviral Drugs
  I. Anti-Human Immunodeficiency Virus Drugs
  II. Anti-Herpersvirus Drugs
  III. Anti-Influenza Drugs
  IV. Anti-Hepacivirus Drugs
Chapter 41  Antimycobacterial Drugs
  I. Introduction
  II. First-Line Drugs Used in Tuberculosis
  III. Alternative Second-Line Drugs in Treatment of Tuberculosis
  IV. Combination Chemotherapy of Tuberculosis
Chapter 42  Antimalarial Drugs
  I. Plasmodium Life Cycles and Action of Antimalarial Drugs
  II. Antimalarial Drugs Mainly Applied to Control Symptoms
  III. Antimalarial Drugs Mainly Applied to Control Relapse and Transmission
  IV. Antimalarial Drugs Mainly Applied to Causal Prophylaxis
Chapter 43  Amebicides
  I. Life Cycles of Entamoeba Histolytica and Action of Amebicides
  II. Luminal Amebicides
  III. Extraintestinal Amebicides
  IV. Luminal and Simultaneously Extraintestinal Amebicides
Chapter 44  Anthelmintic Drugs
  I. Nematocides
  II. Taeniacides
  III. Anti-Trematode Drugs
Chapter 45  Antineoplastic Drugs
  I. Introduction
  II. Cytotoxic Drugs
  III. Non-Cytotoxic Drugs
References